These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Permeability changes in response to NONOate and NONOate prodrug derived nitric oxide in a blood-brain barrier model formed by primary porcine endothelial cells. Winter S; Konter J; Scheler S; Lehmann J; Fahr A Nitric Oxide; 2008 May; 18(3):229-39. PubMed ID: 18284923 [TBL] [Abstract][Full Text] [Related]
3. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-carboxymethylphenyl)-1-(4-methanesulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its aminosulfonyl analog: Synthesis, biological evaluation and nitric oxide release studies. Abdellatif KR; Chowdhury MA; Dong Y; Das D; Yu G; Velázquez C; Suresh MR; Knaus EE Bioorg Med Chem; 2009 Jul; 17(14):5182-8. PubMed ID: 19500994 [TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships for 4-nitrobenzyl carbamates of 5-aminobenz[e]indoline minor groove alkylating agents as prodrugs for GDEPT in conjunction with E. coli nitroreductase. Hay MP; Atwell GJ; Wilson WR; Pullen SM; Denny WA J Med Chem; 2003 Jun; 46(12):2456-66. PubMed ID: 12773049 [TBL] [Abstract][Full Text] [Related]
5. Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies. Velázquez CA; Chen QH; Citro ML; Keefer LK; Knaus EE J Med Chem; 2008 Mar; 51(6):1954-61. PubMed ID: 18314945 [TBL] [Abstract][Full Text] [Related]
6. E. coli nitroreductase/CB1954 gene-directed enzyme prodrug therapy: role of arylamine N-acetlytransferase 2. Mitchell DJ; Minchin RF Cancer Gene Ther; 2008 Nov; 15(11):758-64. PubMed ID: 18600257 [TBL] [Abstract][Full Text] [Related]
7. The nitric oxide prodrug JS-K and its structural analogues as cancer therapeutic agents. Maciag AE; Saavedra JE; Chakrapani H Anticancer Agents Med Chem; 2009 Sep; 9(7):798-803. PubMed ID: 19538173 [TBL] [Abstract][Full Text] [Related]
8. Cellular distribution studies of the nitric oxide-generating antineoplastic prodrug O(2) -(2,4-dinitrophenyl)1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate formulated in Pluronic P123 micelles. Kaur I; Terrazas M; Kosak KM; Kern SE; Boucher KM; Shami PJ J Pharm Pharmacol; 2013 Sep; 65(9):1329-36. PubMed ID: 23927471 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of nitroheterocyclic carbamate prodrugs for use with nitroreductase-mediated gene-directed enzyme prodrug therapy. Hay MP; Anderson RF; Ferry DM; Wilson WR; Denny WA J Med Chem; 2003 Dec; 46(25):5533-45. PubMed ID: 14640560 [TBL] [Abstract][Full Text] [Related]
10. Targeted diazeniumdiolates: localized nitric oxide release from glioma-specific peptides and proteins. Safdar S; Taite LJ Int J Pharm; 2012 Jan; 422(1-2):264-70. PubMed ID: 22101282 [TBL] [Abstract][Full Text] [Related]
11. Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies. Abdellatif KR; Chowdhury MA; Dong Y; Velázquez C; Das D; Suresh MR; Knaus EE Bioorg Med Chem; 2008 Nov; 16(22):9694-8. PubMed ID: 18930406 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, mechanistic studies, and anti-proliferative activity of glutathione/glutathione S-transferase-activated nitric oxide prodrugs. Chakrapani H; Kalathur RC; Maciag AE; Citro ML; Ji X; Keefer LK; Saavedra JE Bioorg Med Chem; 2008 Nov; 16(22):9764-71. PubMed ID: 18930407 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological evaluation of cyclic and acyclic nitrobenzylphosphoramide mustards for E. coli nitroreductase activation. Jiang Y; Han J; Yu C; Vass SO; Searle PF; Browne P; Knox RJ; Hu L J Med Chem; 2006 Jul; 49(14):4333-43. PubMed ID: 16821793 [TBL] [Abstract][Full Text] [Related]
17. Investigation of alternative prodrugs for use with E. coli nitroreductase in 'suicide gene' approaches to cancer therapy. Bailey SM; Knox RJ; Hobbs SM; Jenkins TC; Mauger AB; Melton RG; Burke PJ; Connors TA; Hart IR Gene Ther; 1996 Dec; 3(12):1143-50. PubMed ID: 8986441 [TBL] [Abstract][Full Text] [Related]